Gene Therapy from A to Z. Patient Perspective on Gene Therapy

Course information

Teaching objective
This course provides information on what patients expect from gene therapy in neuromuscular diseases. Furthermore, patient selection, education and follow-up care for gene therapy in hemophilia are explained.

Primary target group:
Physicians of all disciplines

Scientific director/lecturer:
Priv.-Doz. Dr. Robert Klamroth
Klinik für Innere Medizin – Angiologie und Hämostaseologie
Klinikum im Friedrichshain, Berlin

Lecturer:
Prim. Dr. Rudolf Schwarz
Abteilung Kinder- und Jugendheilkunde
Landesklinikum Amstetten

DFP-points:
For correctly answering the multiple-choice questions 1 point is awarded for the Diploma Continuing Education Programme of the Austrian Medical Association.

Medical speciality:
all disciplines

Lecture Board:
Ass.-Prof. Dr. med. univ. Andreas Reinisch, PhD
Universitätsklinik für Innere Medizin, Klinische Abteilung für Hämatologie,
Universitätsklinik für Blutgruppenserologie und Transfusionsmedizin
Medizinische Universität Graz

Ao. Univ.-Prof. Dr. Werner Streif
Department für Kinder und Jugendheilkunde
Tirol Kliniken, Medizinische Universität Innsbruck

Medical training provider:
Gesellschaft der Ärzte

Organisation:
Universimed Cross Media Content GmbH

Cost:
This course is provided to you free of charge.

Disclosure Statement:
All persons presenting at this course or contributing to the content have been asked to disclose any conflicts of interest that may exist that could be associated with influencing the course content.

Sponsor:
Pfizer Corporation Austria Ges.m.b.H.

Valid until:
August 2024

_{PP-UNP-AUT-0072/05.2022}